2024-03-19 19:52:33 ET
Summary
- John Paulson's 13F portfolio value decreased slightly from $1.12B to $1.11B in the last quarter.
- The top five positions in Paulson's portfolio are Madrigal Pharma, Bausch Health, Brightsphere Investment Group, NovaGold, and Perpetua Resources.
- Paulson made stake increases in Madrigal Pharma, NovaGold Resources, and Newmark Group, while keeping steady positions in Bausch Health, Brightsphere Investment Group, and Perpetua Resources.
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 2/14/2024. Please visit our Tracking John Paulson’s Paulson & Company Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q3 2023....
Read the full article on Seeking Alpha
For further details see:
Tracking John Paulson's Paulson & Company Portfolio - Q4 2023 Update